132 related articles for article (PubMed ID: 4096253)
1. [Hypolipemic effect of amino acid derivatives of clofibric acid].
Wójcicki J; Samochowiec L; Gawrońska-Szklarz B; Kwapiszewski W; Borkowski L
Acta Pol Pharm; 1985; 42(3):305-8. PubMed ID: 4096253
[No Abstract] [Full Text] [Related]
2. Hypolipemic activity of plafibride.
Bruseghini L; Vilageliu J; Bagaria A
Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
[TBL] [Abstract][Full Text] [Related]
3. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action].
Dănilă G; Nechifor M; Filip M; Păduraru I; Ifrim C; Grădinariu D; Papa V; Manolescu A; Bădescu A
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):127-32. PubMed ID: 3393745
[No Abstract] [Full Text] [Related]
4. Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
Ribalta JM; Artús JJ; Salvador L; Roma E; Vilageliu J; Freixes J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1782-6. PubMed ID: 6797442
[TBL] [Abstract][Full Text] [Related]
5. Hypolipemic profile of plafibride in a model of experimental atherosclerosis.
Badimón JJ; Padró T; Cánovas M; Vidal M; Villaverde CA
Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):613-7. PubMed ID: 6668971
[TBL] [Abstract][Full Text] [Related]
6. [Plafibride--is it an effective drug as a hypolipemic agent?].
Joven J
Med Clin (Barc); 1985 Apr; 84(15):632. PubMed ID: 3999857
[No Abstract] [Full Text] [Related]
7. [Amino acid derivatives of 2-(p-chlorophenoxy)-2-methylpropionic acid as compounds with potential antilipemic agents. II. Preparation of methyl esters of N-[2-(p-chlorophenoxy)-2-methylpropionyl] amino acids].
Kwapiszewski W; Borkowski L
Acta Pol Pharm; 1987; 44(2):121-31. PubMed ID: 3434313
[No Abstract] [Full Text] [Related]
8. [Toxic myopathy due to hypolipemic agents].
Bourrier P; Subra JF; Chennebault JM; Spiesser R; Laine P
Therapie; 1990; 45(4):360. PubMed ID: 2399525
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic approach of plafibride in rat.
Zapatero D; Vilageliu J; Torres A; Ribalta JM; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1800-4. PubMed ID: 7198457
[TBL] [Abstract][Full Text] [Related]
10. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
Altomonte L; Mingrone G; Negrini A; De Cunto F; Greco AV
Clin Ter; 1981 Jan; 96(1):31-8. PubMed ID: 7016409
[No Abstract] [Full Text] [Related]
11. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
Altomonte L; Mingrone G; Ghirlanda G; Manna R; Rebuzzi A; Pala MA; Greco AV
Minerva Med; 1980 Feb; 71(4):273-8. PubMed ID: 7354946
[TBL] [Abstract][Full Text] [Related]
12. Effect of peroxisomes proliferators and hypolipemic agents on mitochondrial inner membrane linked D-3-hydroxybutyrate dehydrogenase (BDH).
el Kebbaj MH; Cherkaoui Malki M; Latruffe N
Biochem Mol Biol Int; 1995 Jan; 35(1):65-77. PubMed ID: 7735141
[TBL] [Abstract][Full Text] [Related]
13. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
Metz G; Specker M
Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
[TBL] [Abstract][Full Text] [Related]
14. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
Słowińska R; Bochenek W; Unlot J
Pol Tyg Lek; 1983 Apr; 38(17):529-32. PubMed ID: 6356087
[No Abstract] [Full Text] [Related]
15. Influence of plafibride, an antiplatelet and hypolipemic agent, on prostacyclin and thromboxane synthesis, 3',5'-cyclic AMP phosphodiesterase activity and serum clearance of a lipid emulsion.
Vilageliu J; Freixes J; Giráldez A; Bermejo P; Basi N; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1805-7. PubMed ID: 6274363
[TBL] [Abstract][Full Text] [Related]
16. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology and mechanism of action of etofibrate].
Schatton W
Med Welt; 1982 Sep; 33(38):1310-4. PubMed ID: 6752630
[No Abstract] [Full Text] [Related]
18. [Therapy of vascular insufficiency of the legs with plafibride].
Lázaro Campillo T; Gesto Castromil R; de la Sierra L; Pujadas J; Villafana W; Moreno R
Med Clin (Barc); 1984 Dec; 83(18):752-5. PubMed ID: 6521538
[No Abstract] [Full Text] [Related]
19. Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid.
Ammazzalorso A; Amoroso R; Baraldi M; Bettoni G; Braghiroli D; De Filippis B; Giampietro L; Tricca ML; Vezzalini F
Eur J Med Chem; 2005 Sep; 40(9):918-21. PubMed ID: 15950326
[TBL] [Abstract][Full Text] [Related]
20. Bezafibrate does not influence the QT interval in man.
Olsson AG; Ekelund LG; Lang PD; Vollmar J
J Cardiovasc Pharmacol; 1983; 5(2):341-2. PubMed ID: 6188913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
